Paris, January 21st, 2020 – Ardian, a world leading private investment house, today announces the arrangement of a senior financing facility to support Telemos Capital and MedEuropa’s acquisition of CCO Perpignan. The financing package also includes a committed acquisition facility to finance future build-ups.

MedEuropa is a European cancer care company with a strong focus on radiotherapy. Radiotherapy is one of the most commonly used therapies for cancer treatment and consists in the use of high doses of radiation to eliminate cancer cells and shrink tumors. It can be used as a standalone oncology treatment or in combination with other cancer treatments such as surgery or chemotherapy.

Headquartered in Switzerland, the MedEuropa platform was founded in 2017 by Telemos Capital. The network was initially created through the acquisition of two radiotherapy centers in Germany in January 2019 (Krefeld and Hannover, the leading providers of Gamma Knife treatments, a specialized application of radiotherapy for complex brain tumors) and is to be further enlarged through the acquisition of CCO Perpignan, a radiotherapy center in the South of France.

The combination of all three entities will form a Group operating a total of six treatment machines treating a total c. 2,900 patients per year. As has been the case with the German acquisitions, MedEuropa will continue to partner with the CCO Perpignan doctors, ensuring continuity of high-quality care for patients and referring physicians.

Guillaume Chinardet, Head of Ardian Private Debt France, said: “We look forward to the long term cooperation with the MedEuropa management team and Telemos Capital, valuable partners with strong expertise in the European healthcare services market. We are convinced that MedEuropa will achieve further growth via strategic acquisitions in the fragmented European radiotherapy market.”

Jean-David Ponsin, Managing Director at Ardian Private Debt, further added: ”We are pleased to support the Group in this new chapter of its growth journey and we are convinced that our financing solution will provide the Group with the flexibility to pursue its future development.”

Ralph Hefti, MedEuropa’s CEO, commented: “Ardian’s ability to offer a flexible solution to the Group’s requirements was key to this partnership. Ardian has been extremely responsive and creative and has set up financing that is perfectly suited to the way MedEuropa intends to move forward.”

Nils Hagerstål, Vice President at Telemos Capital concluded: ”MedEuropa is actively considering further acquisition opportunities in the radiotherapy market, with the aim of building a platform in Western Europe. This ambitious development strategy demands a solid yet flexible financing solution, which Ardian has successfully provided.”

 The CCO Perpignan center is located in Perpignan, in the South of France. It focuses on radiotherapy treatments through the operation of linear accelerators, treating a total 1,800 patients. It also provides some chemotherapy treatments in a more limited manner. CCO Perpignan enjoys a strong local reputation in the Pyrenées-Orientales region, and is known for providing high quality treatments to patients.

 Founded in 2017, MedEuropa is committed to providing state of the art cancer treatment across Europe, with a strong focus on radiotherapy. MedEuropa seeks to partner with leading medical professionals, who share its vision of improving the provision and quality of cancer treatment.  MedEuropa is pursuing an ambitious buy and build strategy, focusing on new partnership and acquisition opportunities across Europe.

Ardian is a world-leading private investment house with assets of US$96bn managed or advised in Europe, the Americas and Asia. The company is majority-owned by its employees. It keeps entrepreneurship at its heart and focuses on delivering excellent investment performance to its global investor base.
Through its commitment to shared outcomes for all stakeholders, Ardian’s activities fuel individual, corporate and economic growth around the world.
Holding close its core values of excellence, loyalty and entrepreneurship, Ardian maintains a truly global network, with more than 640 employees working from fifteen offices across Europe (Frankfurt, Jersey, London, Luxembourg, Madrid, Milan, Paris and Zurich), the Americas (New York, San Francisco and Santiago) and Asia (Beijing, Singapore, Tokyo and Seoul). It manages funds on behalf of around 1,000 clients through five pillars of investment expertise: Fund of Funds, Direct Funds, Infrastructure, Real Estate and Private Debt.

Telemos Capital invests in private European businesses, with the aim of building great companies for the long term. Funded by family capital, it combines the flexibility and nimble decision-making of a family office with the active ownership and professionalism of private equity. Telemos looks to deploy €50m-€200m of equity per investment and seeks to acquire majority stakes in businesses with the potential for sustainable growth through international expansion, add-on acquisitions or operational improvements.

MedEuropa: Ralph Hefti, Raffael Kabir
Telemos Capital: Philippe Jacobs, Jacob Polny, Nils Hagerstål, Dipesh Mahtani
Ardian Private Debt: Guillaume Chinardet, Jean-David Ponsin, Gabrielle Philip

Financing Legal Advisor (Telemos Capital): Willkie Farr & Gallagher – Paul Lombard, Mathilde de Wiljes
Financing Legal Advisor (Ardian): Allen & Overy – Jean-Christophe David, Marine Tarditi, Adrien Repiquet

Paris, January 17, 2020 – Ardian, a world-leading private investment house, today announces that it has signed an agreement to acquire a majority stake in Santé Cie, a specialist in home medical assistance. Ardian will invest alongside HLD and UI Gestion, company shareholders since 2015, and the management team, to continue the consolidation of the French market and develop internationally.

With this investment, Ardian will enter the home medical assistance market. It offers the Group the opportunity to operate in a new, particularly attractive healthcare segment, while having a very positive social and societal impact. Santé Cie’s business addresses deep demographic, sociological and health challenges tied to an ageing population, an increasing prevalence of chronic illnesses, and a medical desertification in French rural areas.

Through its two operating networks, Elivie and Asdia, Santé Cie is among the most dynamic players in the home medical assistance sector in France. As a multi-specialist, it addresses the needs of patients in respiratory assistance, insulin therapy, perfusion, nutrition, post-operative care and wound treatment and healing. The company accompanies more than 150,000 patients annually and reported revenue of €240 million in 2019. It has nearly 1,700 employees and its 80 agencies offer services throughout France.

This transaction remains subject to antitrust approval and the opinion of the work council.

Larbi Hamidi, Chairman of Santé Cie: “This is a new impetus for our business. We’ll be able to actively contribute to consolidating the French market and launching our European expansion, but also investing in innovative solutions to improve the efficiency of care pathways in the face of new challenges posed by connected healthcare and telehealth.”

Jean-Bernard Lafonta, Chairman of HLD Europe, said: “We’re proud of Santé Cie’s journey since 2015 to have become one of the leading home medical assistance players in France. We’re delighted to continue our commitment alongside Santé Cie’s management to develop the business internationally and explore promising new segments such as dialysis at home.”

Olivier Jarrousse, Managing Partner of UI Gestion, added: “We’re very pleased with Santé Cie’s progress over the past 5 years and we wish to continue our active contribution to the Group’s development.”

Yann Bak, Managing Director in the Ardian Buyout team, said: ” We’re proud to enter Santé Cie’s share capital alongside existing shareholders and are confident that home medical assistance providers, by assisting patients and ensuring they are monitored by practitioners, have a role to play in the French healthcare value chain .”

Nicolas Darnaud, Managing Director in the Ardian Buyout team, added: “Santé Cie’s strong competitive advantages, its management, its scalable structure, its proven expansion and diversification capabilities, and its many growth options give it significant room for further growth in a fast-expanding market.”

Ardian is a world-leading private investment house with assets of US$96bn managed or advised in Europe, the Americas and Asia. The company is majority-owned by its employees. It keeps entrepreneurship at its heart and focuses on delivering excellent investment performance to its global investor base.
Through its commitment to shared outcomes for all stakeholders, Ardian’s activities fuel individual, corporate and economic growth around the world.
Holding close its core values of excellence, loyalty and entrepreneurship, Ardian maintains a truly global network, with more than 640 employees working from fifteen offices across Europe (Frankfurt, Jersey, London, Luxembourg, Madrid, Milan, Paris and Zurich), the Americas (New York, San Francisco and Santiago) and Asia (Beijing, Singapore, Tokyo and Seoul). It manages funds on behalf of around 1,000 clients through five pillars of investment expertise: Fund of Funds, Direct Funds, Infrastructure, Real Estate and Private Debt.Follow Ardian on Twitter @Ardian

Created in 2016, Santé Cie is the third largest home healthcare provider in France, through its two operating networks Elivie and Asdia.
With the trust of healthcare professionals, the company supports nearly 150,000 home care patients, both children and adults, across France every day. It covers a wide range of therapeutic segments including perfusion, nutrition, insulin therapy, the treatment of Parkinson’s disease, respiratory assistance and wound treatment and healing.
By means of a medical prescription, the Elivie and Asdia teams set up all equipment required at home for the care of patients with chronic or acute illnesses. By ensuring the home care pathway, training and patient support and monitoring, the teams provide solutions to simplify and secure patient care at home, in constant contact with prescribers and in coordination with their entourage and all participants in the care chain (pharmacists, nurses, physiotherapists, etc.)
Santé Cie has nearly 1,700 employees across 80 agencies throughout France, through its Elivie and Asdia networks.

Created in 2010 by Jean-Philippe Hecketsweiler, Jean-Bernard Lafonta and Philippe Donnet, HLD has experienced remarkable growth in the investment capital sector. The investment holding company now has 12 companies in France and Europe (including Tessi, Kiloutou, Coyote, Santé Cie and Rafaut), representing combined revenue of almost €2 billion and 17,000 employees. True to the wishes of its shareholders, which include many European entrepreneurs, including the Decaux, Dentressangle and Claude Bébéar families, HLD invests without any time constraints. This has enabled strong ties to be forged with portfolio company management, and HLD to support the long-term development of companies in Europe and internationally.
The HLD teams are currently present in Europe: Luxembourg, Paris, Milan and Zurich.

A historical investment capital player for 50 years, UI Gestion is an independent management company managing more than €650 million on behalf of leading institutional investors, entrepreneurs and Family Offices.

Independent since 2004, with a regional coverage since 2010 (Paris, Nantes, Rennes, Rheims, Strasbourg and Lille), UI Gestion specializes in developing SMEs and helps their management implement growth projects and buyout and growth transactions. With the UI Academy, management benefit from complementary tools to strengthen the strategic definition of their projects and operational implementation.

Over the past 15 years, UI Gestion has raised more than €1 billion across three investment platforms (regional, national, sector-based) and has supported more than 130 companies, primarily in the health care, agro-business and equipment manufacturing sectors.

Ardian team: Yann Bak, Nicolas Darnaud, Nicolas Kassab, Maxime Debost
M&A Advisor: BNP Paribas (Sylvina Mayer, Marc Walbaum, Sammy Lamali, Clara Blandeau)
Commercial and strategic advisor: LEK (Arnaud Sergent, Serge Hovsepian, Leonore Bosch, Servane Perrot)
Financial DD: 8advisory (Christophe Delas, Christian Berling, Nicolas Bassi)
Legal and Tax Advisor: Latham & Watkins (Gaëtan Gianasso, Thimothée Brunello, Mayssa Sader, Xavier Renard, Yann Auregan)
CSR Advisor: Indefi (Emmanuel Parmentier, Charlotte Salmon)
IT Advisor: 8advisory IT (Jean-Christophe Fuzzati)
Digital Advisor: Singulier (Rémi Pesseguier, Diane Levy)HLD team: Jean-Bernard Lafonta, Maxence Gailliot, Julia Marc
UI Gestion team: Olivier Jarrousse, Sébastien Alauzet, Edouard Vilmer
M&A advisor to the seller: Rothschild (Laurent Baril, Robert Rozemulder)
Financial DD: Accuracy (Arnaud Lambert, Marie Madelpuech)
Legal Advisor: Weil, Gotshal & Manges (Alexandre Duguay, Pierre-Alexandre Khan, Come Wirz, Romain Ferla, Anne-Laila Abback, Cassandre Porgès, Timothée Buchet)